Cerebrospinal Fluid Interleukin-6 as a Diagnostic Biomarker in Neonatal Meningitis: A Hospital-Based Prospective Observational Cross-Sectional Study.

Background: Neonatal meningitis causes substantial mortality and long-term neurological morbidity, yet early diagnosis is difficult because clinical features are nonspecific and conventional cerebrospinal fluid (CSF) investigations have important limitations. CSF interleukin-6 (IL-6) is a candidate early biomarker. Aim: To evaluate the diagnostic accuracy of CSF IL-6 for neonatal meningitis. Materials and Methods: This hospital-based, prospective observational cross-sectional study was conducted in the Neonatal Intensive Care Unit of the Indira Gandhi Institute of Child Health, Bengaluru, from April 2024 to September 2025. A total of 159 neonates with suspected sepsis requiring lumbar puncture were enrolled. Meningitis was defined using National Neonatology Forum (NNF) criteria. CSF IL-6 was measured by electrochemiluminescence immunoassay. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis. Results: Seventy-eight neonates (49.1%) had meningitis. Median CSF IL-6 was higher in the meningitis group than in the non-meningitis group (23.30 vs 5.00 pg/mL; p<0.001). The area under the ROC curve was 0.799 (95% CI 0.731–0.866). At a cut-off of ≥8.22 pg/mL, CSF IL-6 showed 70.5% sensitivity, 70.4% specificity, 69.6% positive predictive value, 71.3% negative predictive value and 70.4% accuracy (positive likelihood ratio 2.38; negative likelihood ratio 0.42). CSF total cell count had the highest area under the curve (0.844). Conclusion: CSF IL-6 is significantly elevated in neonatal meningitis and shows moderate diagnostic accuracy. It is a useful adjunct to, but not a substitute for, conventional CSF examination and culture. Recommendation: CSF IL-6 may be incorporated as a rapid adjunct test in the NICU evaluation of suspected meningitis, interpreted together with CSF cytology, biochemistry and culture. Multicentre studies using culture- or PCR-confirmed reference standards are recommended to validate the proposed cut-off.

Authors

Institutions

Publication Details

Journal
SJ Pediatrics and Child Health Africa
Published
2026-11-14
DOI
https://doi.org/10.51168/60sjmf95
Primary Topic
Neonatal and Maternal Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cerebrospinal Fluid Interleukin-6 as a Diagnostic Biomarker in Neonatal Meningitis: A Hospital-Based Prospective Observational Cross-Sectional Study.

Niranjan H S, Jacqueline Antoinette Shah, Dr. Naveen Kumar P, Dr. Priyanka A.R et al.
SJ Pediatrics and Child Health Africa
Neonatal and Maternal Infections
article

Cerebrospinal Fluid Interleukin-6 as a Diagnostic Biomarker in Neonatal Meningitis: A Hospital-Based Prospective Observational Cross-Sectional Study.

Niranjan H S, Jacqueline Antoinette Shah, Dr. Naveen Kumar P, Dr. Priyanka A.R, Dr. Nivedeetha K, Dr. Prathik B. H
article en

Abstract

Background: Neonatal meningitis causes substantial mortality and long-term neurological morbidity, yet early diagnosis is difficult because clinical features are nonspecific and conventional cerebrospinal fluid (CSF) investigations have important limitations. CSF interleukin-6 (IL-6) is a candidate early biomarker. Aim: To evaluate the diagnostic accuracy of CSF IL-6 for neonatal meningitis. Materials and Methods: This hospital-based, prospective observational cross-sectional study was conducted in the Neonatal Intensive Care Unit of the Indira Gandhi Institute of Child Health, Bengaluru, from April 2024 to September 2025. A total of 159 neonates with suspected sepsis requiring lumbar puncture were enrolled. Meningitis was defined using National Neonatology Forum (NNF) criteria. CSF IL-6 was measured by electrochemiluminescence immunoassay. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis. Results: Seventy-eight neonates (49.1%) had meningitis. Median CSF IL-6 was higher in the meningitis group than in the non-meningitis group (23.30 vs 5.00 pg/mL; p<0.001). The area under the ROC curve was 0.799 (95% CI 0.731–0.866). At a cut-off of ≥8.22 pg/mL, CSF IL-6 showed 70.5% sensitivity, 70.4% specificity, 69.6% positive predictive value, 71.3% negative predictive value and 70.4% accuracy (positive likelihood ratio 2.38; negative likelihood ratio 0.42). CSF total cell count had the highest area under the curve (0.844). Conclusion: CSF IL-6 is significantly elevated in neonatal meningitis and shows moderate diagnostic accuracy. It is a useful adjunct to, but not a substitute for, conventional CSF examination and culture. Recommendation: CSF IL-6 may be incorporated as a rapid adjunct test in the NICU evaluation of suspected meningitis, interpreted together with CSF cytology, biochemistry and culture. Multicentre studies using culture- or PCR-confirmed reference standards are recommended to validate the proposed cut-off.

SJ Pediatrics and Child Health AfricaVol. 3(4)
Indira Gandhi Institute of Child Health (IN)
Neonatal and Maternal Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon